Unfortunately, it is just one-off sales outside the US .
I think I was told A$20,000, versus $8,000(not sure whether that is USD or AUD) in the US. Twodogs or Acclivity will correct that if it is wrong.
The licence fees in the US are what makes the proposition potentially so lucrative - licence fees only possible because of reimbursement. The viability of the business model depends on the US health system. Sad fact.
Unfortunately, it is just one-off sales outside the US .I think...
Add IPD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.004(6.15%) |
Mkt cap ! $139.5M | |||
| Open | High | Low | Value | Volume |
| 6.6¢ | 6.9¢ | 6.5¢ | $138.9K | 2.117M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 6.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 84169 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
6.8¢ |
Change
0.004 ( 4.62 %) |
||||
| Open | High | Low | Volume | ||
| 6.6¢ | 6.8¢ | 6.5¢ | 402373 | ||
| Last updated 15.56pm 14/06/2024 ? | |||||
| IPD (ASX) Chart |